Corvid Pharmaceuticals Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
as on 26-06-2024
- Paid Up Capital ₹ 0.10 M
as on 26-06-2024
- Company Age 12 Year, 3 Months
- Last Filing with ROC 31 Mar 2022
- Revenue 96.58%
(FY 2020)
- Profit 4842.44%
(FY 2020)
- Ebitda 856.75%
(FY 2020)
- Net Worth 63.88%
(FY 2020)
- Total Assets 9.00%
(FY 2020)
About Corvid Pharmaceuticals
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2022. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Swati Hedaoo, Vijay Kolhekar, Rajesh Hedaoo, and One other member serve as directors at the Company.
- CIN/LLPIN
U33100MH2012PTC235053
- Company No.
235053
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
28 Aug 2012
- Date of AGM
30 Sep 2022
- Date of Balance Sheet
31 Mar 2022
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Company Details
- Location
Raigarh, Maharashtra, India
- Telephone
- Email Address
- Website
- Social Media-
What products or services does Corvid Pharmaceuticals Private Limited offer?
Corvid Pharmaceuticals Private Limited offers a wide range of products and services, including Business Planning and Management, Business Consultant, Medical Consultants & Clinics, Medical Consultancy Services, Pharmaceutical Consultants, Pharma & Bioanalytical Services, Pharmaceutical Services, Laboratory Apparatus, Chemistry Lab Apparatus.
Who are the key members and board of directors at Corvid Pharmaceuticals?
Board Members(4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Vijay Kolhekar  | Director | 28-Aug-2012 | Current |
| Swati Hedaoo | Director | 28-Aug-2012 | Current |
| Rajesh Hedaoo | Director | 26-May-2016 | Current |
| Harendra Singh | Director | 28-Aug-2012 | Current |
Financial Performance and Corporate Structure Insights of Corvid Pharmaceuticals.
Corvid Pharmaceuticals Private Limited, for the financial year ended 2020, experienced significant growth in revenue, with a 96.58% increase. The company also saw a substantial improvement in profitability, with a 4842.44% increase in profit. The company's net worth Soared by an impressive increase of 63.88%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Corvid Pharmaceuticals?
In 2019, Corvid Pharmaceuticals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Ascent Total Solution Private LimitedActive 10 years 5 monthsVijay Kolhekar and Rajesh Hedaoo are mutual person
Apicem Technobuild Private LimitedActive 5 years 10 monthsVijay Kolhekar and Rajesh Hedaoo are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Corvid Pharmaceuticals?
Unlock and access historical data on people associated with Corvid Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Corvid Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Corvid Pharmaceuticals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
